Clinical Trial Update: Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing efficacy and safety of Symbicort Turbuhaler, Seretide Diskus 50/500 µg, and Terbutaline Turbuhaler in asthma patients; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Seretide Diskus 50/500 µg (fluticasone propionate/salmeterol)
• Symbicort Turbuhaler (budesonide/formoterol)
• Terbutaline Turbuhaler 0.4 mg (terbutaline)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED